Trial intelligence / Profile preview

PPI vs H2RA for prevention of postoperative delirium after elderly hepatobiliary-pancreatic surgery

jRCTs041260118Phase 3Recruiting

Start
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative delirium (POD) comparing PPI group with H2RA group (2 arms). Primary endpoint: Incidence of delirium on postoperative days 1-3. Started Sep 2026; status: recruiting.

02

Drugs

omeprazolefamotidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on jRCTs041260118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041260118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call